Abbott Q4 sales $10.1B, full-year GAAP EPS $3.91; guides FY23 adj. EPS $4.30-4.50

ABBOTT LABORATORIES

2022-FY EPS reported $3.91 revenue$43,653,000,000

Q4 GAAP diluted EPS $0.59; adjusted diluted EPS $1.03; full-year GAAP EPS $3.91, adjusted $5.34.
Full-year sales flat at $43.7B; organic growth 6.4%; COVID-testing sales $8.4B vs. $7.7B in 2021.
2023 guidance: GAAP EPS $3.05-3.25, adjusted EPS $4.30-4.50; organic growth ex-COVID high-single digits.
Quarterly dividend of $0.51 per share declared, payable Feb. 15, 2023; 51 consecutive years of increases.
FreeStyle Libre Q4 sales ~$1.1B; U.S. growth >40%; FDA approvals for Navitor TAVI and Eterna SCS.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

ABBOTT LABORATORIES reported full year 2022 results: revenue $43.7 billion, EPS $3.91. Guidance initiated.

Period: full year 2022
Revenue: $43.7 billion
EPS: $3.91
Guidance: initiated
Result: reported results

Exact text from the filing

--- News Release Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook – Fourth-quarter sales of $10.1 billion; full-year 2022 sales of $43.7 billion – Full-year 2022 sales growth of 1.3 percent; organic sales growth of 6.4 percent – Full-year 2022 GAAP diluted EPS of $3.91; adjusted diluted EPS of $5.34 – Continues to

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

ABBOTT LABORATORIES reported the fourth quarter ended Dec. 31, 2022 results: revenue $10.1 billion, EPS $0.59.

Period: the fourth quarter ended Dec. 31, 2022
Revenue: $10.1 billion
EPS: $0.59
Result: reported results

Exact text from the filing

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2022. • Fourth-quarter sales of $10.1 billion

View on SEC.gov

Browse all earnings releases →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001628280-23-001516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.